These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9476516)

  • 1. Itraconazole susceptibility of feline isolates of Microsporum canis.
    Mancianti F; Zullino C; Papini R
    Mycoses; 1997 Nov; 40(7-8):313-5. PubMed ID: 9476516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antifungal activity of some essential oils against feline isolates of Microsporum canis.
    Mugnaini L; Nardoni S; Pinto L; Pistelli L; Leonardi M; Pisseri F; Mancianti F
    J Mycol Med; 2012 Jun; 22(2):179-84. PubMed ID: 23518021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine.
    Perrins N; Bond R
    Vet Dermatol; 2003 Apr; 14(2):99-102. PubMed ID: 12662267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first report of terbinafine resistance Microsporum canis from a cat.
    Hsiao YH; Chen C; Han HS; Kano R
    J Vet Med Sci; 2018 Jun; 80(6):898-900. PubMed ID: 29657238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility to antimycotics of Microsporum canis isolates from cats.
    Puccini S; Valdré A; Papini R; Mancianti F
    J Am Vet Med Assoc; 1992 Nov; 201(9):1375-7. PubMed ID: 1429182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal and marker effects of Talisia esculenta lectin on Microsporum canis in vitro.
    Pinheiro AQ; Melo DF; Macedo LM; Freire MG; Rocha MF; Sidrim JJ; Brilhante RS; Teixeira EH; Campello CC; Pinheiro DC; Lima MG
    J Appl Microbiol; 2009 Dec; 107(6):2063-9. PubMed ID: 19558469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis.
    Mancianti F; Pedonese F; Millanta F; Guarnieri L
    J Feline Med Surg; 1999 Mar; 1(1):37-41. PubMed ID: 11919014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomycetoma caused by Microsporum canis in a Persian cat: lack of response to oral terbinafine.
    Bond R; Pocknell AM; Tozet CE
    J Small Anim Pract; 2001 Nov; 42(11):557-60. PubMed ID: 11721986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs against Microsporum canis.
    Tabart J; Baldo A; Vermout S; Losson B; Mignon B
    Vet Dermatol; 2008 Jun; 19(3):130-3. PubMed ID: 18477328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of topical therapies for the treatment of dermatophyte-infected hairs from dogs and cats.
    White-Weithers N; Medleau L
    J Am Anim Hosp Assoc; 1995; 31(3):250-3. PubMed ID: 7634061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal flora of the haircoat of cats with and without dermatophytosis.
    Moriello KA; Deboer DJ
    J Med Vet Mycol; 1991; 29(5):285-92. PubMed ID: 1955948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility and genotypical pattern of Microsporum canis strains.
    Brilhante RS; Cordeiro RA; Medrano DJ; Monteiro AJ; Sidrim JJ; Rocha MF
    Can J Microbiol; 2005 Jun; 51(6):507-10. PubMed ID: 16121230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.
    Hofbauer B; Leitner I; Ryder NS
    Med Mycol; 2002 Apr; 40(2):179-83. PubMed ID: 12058731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates.
    Moriello KA; Deboer DJ; Volk LM; Sparkes A; Robinson A
    Vet Dermatol; 2004 Jun; 15(3):175-80. PubMed ID: 15214954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral administration of itraconazole to cats with dermatophytosis caused by Microsporum canis.
    Mancianti F; Pedonese F; Zullino C
    J Am Vet Med Assoc; 1998 Oct; 213(7):993-5. PubMed ID: 9776995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Microsporum canis arthrospores to a mixture of chemically defined essential oils: a perspective for environmental decontamination.
    Nardoni S; Tortorano A; Mugnaini L; Profili G; Pistelli L; Giovanelli S; Pisseri F; Papini R; Mancianti F
    Z Naturforsch C J Biosci; 2015; 70(1-2):15-24. PubMed ID: 25854840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of itraconazole as a combined continuous/pulse therapy in feline dermatophytosis: preliminary results in nine cases.
    Colombo S; Cornegliani L; Vercelli A
    Vet Dermatol; 2001 Dec; 12(6):347-50. PubMed ID: 11844225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach of dermatophytosis eradication in shelters: effect of Pythium oligandrum on Microsporum canis in FIV or FeLV positive cats.
    Načeradská M; Fridrichová M; Kolářová MF; Krejčová T
    BMC Vet Res; 2021 Sep; 17(1):290. PubMed ID: 34470629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitic relationship between Microsporum canis and the cat.
    Pier AC; Moriello KA
    Med Mycol; 1998; 36 Suppl 1():271-5. PubMed ID: 9988517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of griseofulvin and itraconazole in the treatment of experimentally induced dermatophytosis in cats.
    Moriello KA; DeBoer DJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):439-44. PubMed ID: 7591941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.